The drop represents a return to a more normal pace of openings post-pandemic but likely also reflects the reimbursement and regulatory challenges facing the industry.

Quest will become the exclusive independent national laboratory provider of clinical lab and anatomic pathology services for Sentara members in Florida and Virginia.

The Baltimore-based subsidiary of Japan's Sysmex said that the test is used to identify genetic mutations that are relevant for the treatment of various cancer types.

NEW YORK – A group of researchers from the University of North Carolina, Chapel Hill have validated an array-based assay for subtyping pancreatic cancer that they believe may help determine which ...

NEW YORK – Laboratory Corporation of America said Tuesday that it is acquiring a 15 percent indirect minority stake in European diagnostics and testing outfit SYNLAB from private equity firm Cinven ...